Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
ALK inhib
Welcome,
Profile
Billing
Logout
29 Companies
27 Products
27 Products
124 Diseases
262 Trials
19352 News
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
19
38
57
76
95
114
133
152
171
190
Xalkori
(crizotinib) / Pfizer
Alecensa
(alectinib) / Roche
Lorbrena
(lorlatinib) / Pfizer
Xospata
(gilteritinib) / Astellas
Zykadia
(ceritinib) / Novartis
Alunbrig
(brigatinib) / Takeda
Rozlytrek
(entrectinib) / Roche
Ensacove
(ensartinib) / Xcovery
Augtyro
(repotrectinib) / BMS
Qi Xinke
(iruplinalkib) / Qilu Pharma
XZP-3621
/ Sihuan Pharmaceutical
TGRX-326
/ Shenzhen TargetRx
envonalkib
(TQ-B3139) / Sino Biopharm, Shouyao Holdings
ficonalkib
(SY-3505) / Shouyao Holdings
unecritinib
(TQ-B3101) / Sino Biopharm
alkotinib
(ZG0418) / Suzhou Zelgen
conteltinib
(SY-707) / Centaurus Biopharma, Shouyao Holdings
APG-2449
/ Ascentage Pharma
ASP-3026
/ Astellas
NVL-655
/ Nuvalent
belizatinib
(TSR-011) / GSK
foritinib
(SAF-189) / Fosun Pharma
CEP-37440
/ Teva
PLB 1003
/ Avistone Biotech
RF-A089
/ Humanwell Healthcare
TPX-0131
/ BMS
TY-2136b
/ TYK Medicines, Livzon Pharma
